Citius Pharma (CTXR) to Merge Subsidiary, with Publicly Traded SPAC. Shares up 17%.

We Would Define This as Huge News.. Citius Pharma would receive 67.5...

Is Ardelyx (ARDX) $4.00 Ready to Break Out?

We're up 160% ($579 million) in Ardelyx since adding it to the Watch List about ten months ago in November, but we...
DarioHealth,

Plansource Invites DarioHealth (DRIO) Into 50 Broker Partnership Network, Serving 5 Million Patients.

This looks like a coup for DarioHealth (DRIO), getting it's digital health solutions in front of more than 5 million new potential...

With Help of Sanofi (SNY), Dario Health (DRIO) Builds Scientific Case for Its Diabetes...

We always find it Interesting when a Company with a $130 billion market cap (Sanofi: SNY), teams up with a Company...

Adding Dario Health (DRIO) $2.81 to Watch List.

LIVE QUOTE Adding DarioHealth to Top Stocks of 2023...

Tsunami of Business Headed Pressure Bio’s (PBIO) Way?

We think there is a potential Tsunami of business headed towards Pressure Bio over then next 3-5 years. And well beyond....

Report: Is Psycheceutical BioScience (BWVI) One of the Most Important Companies in the Psychedelic...

Initiating Coverage on Psycheceutical BioScience (BWVI). "Imagine Applying a Psychedelic Topically, Receiving the Benefits...

Hepion Pharmaceuticals (HEPA) Announces Passing of Key Safety Milestone in Phase 2b ‘ASCEND-NASH’ Trial...

Completion of Enrollment Remains on Track for Q1, 2024 "While we recently had fireworks, we could be looking at...

Psycheceutical’s (BWVI) NeuroDirect™ Ketamine can Help Alleviate Headaches and Migraines Within Minutes, With no...

Photo MAPS Founder Rick Doblin visits Psycheceutical's Chief Visionary Officer Mike 'Zappy' Zapolin, CEO Chad Harman at the company's lab and tests...

Psycheceutical Bioscience (BWVI) Secures Funding for Clinical Trials

Psycheceutical Secures Funding for Clinical Trials of NeuroDirect™ Ketamine Topical to Treat PTSD. Company raises $1.3M USD convertible note...

Latest article

Post Reverse Split, Tharimmune (THAR) Announces Positive Phase I Results.

This is a story of 're-purposed' FDA approved drug, from drug overdose, to a solution for unrelenting itching. If approved, it can...

Trump’s (DJT) up 48% Today

LIVE QUOTE Our only thought is it would be a great idea, to give...

Altamira Thera (CYTO) Explodes 144% Higher Post Reverse Split, With 50 Million Shares Trading...

Taking advantage of post reverse-split investor pessimism, is a VALID investing technique. Altamira is developing and supplying peptide-based...